New labs for the Sbarro Institute
October 22, 2009 | Philadelphia, Pennsylvania | Vetting explained
On October 27 2009, the Sbarro Institute (S.H.R.O) of Philadelphia, PA, will host a meeting to show its new laboratories.
Several noticeable representatives of the State of Pennsylvania will take part to the event, as the Cardinal Justin Francis Rigali, the Archbishop of Philadelphia, the Honorable Sam Smith and Mario J. Civera. To represent the Temple University, Ann Weaver Hart, the President of Temple University, and Hai-Lung Dai, Ph.D., the Dean of Temple University’s College of Science and Technology.
The Institute, founded and directed by prof. Antonio Giordano M.D. Ph.D. will be always located inside the Biolife Science Bldg inside the Temple University of Philadelphia, PA, but it will be moved to another floor able to offer more spaces for new labs, a meeting area and a conference room.
Info:
SBARRO HEALTH RESEARCH ORGANIZATION (SHRO)
The SHRO is dedicated to supporting scientific research aimed at finding cures for cancer, cardiovascular and other diseases by identifying their underlying molecular mechanisms. SHRO includes the Sbarro Institute for Cancer Research and Molecular Medicine located at Temple University in Philadelphia
Pierpaolo Basso
Sbarro Health Press
- Posted in Assignment:
- Breaking news
iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.
What is iReport?
-
Share
Tell a story, offer an opinion, say what's important to you.
-
Discuss
Join the conversation on the day's big issues.
-
Be heard
The best iReports get vetted and used on CNN platforms.
The label “Not vetted by CNN” lets you know that this story hasn’t been both checked and cleared by a CNN editor.
iReport stories that have a red "CNN iReport" stamp in the corner have been vetted and
cleared. That means they've been selected and approved by a CNN producer to use on CNN,
on air, or on any of CNN's platforms.






Comments